Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. 2009

Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
The Feinstein Institute for Medical Research, North Shore-Long Island Jewish (LIJ) Health System, Manhasset, NY 11030, USA.

Despite a wealth of information about the structure of surface membrane immunoglobulin (smIg) on chronic lymphocytic leukemia (CLL) cells, little is known about epitopes reacting with their binding sites. Probing phage-displayed peptide libraries, we identified and characterized mimetopes for Igs of 4 patients with IGHV mutated CLL (M-CLL) and 4 with IGHV unmutated CLL (U-CLL). Six of these mAbs were representatives of stereotyped B-cell receptors characteristic of CLL. We found that mimetic epitopes for U- and M-CLL Igs differed significantly. M-CLL-derived peptides exhibited better amino acid motifs, were more similar to each other, aligned more easily, and formed tighter clusters than U-CLL-derived peptides. Mono-, oligo-, and polyreactivity of peptides correlated with structural changes within antigen-binding sites of selecting M-CLL mAbs. Although M-CLL-isolated peptides and certain U-CLL mAbs bound more effectively to the selecting mAb, others were not as specific, reacting with M-CLL and U-CLL mAbs; these data suggest that in vivo structurally diverse epitopes could bind smIgs of distinct CLL clones, thereby altering survival and growth. Finally, an M-CLL-derived peptide inhibited, in a dose-dependent manner, binding of its homologous mAb to human B lymphocytes; therefore peptides that inhibit or alter the consequences of antigen-smIg interactions may represent therapeutic modalities in CLL.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
August 1997, Infection and immunity,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
January 2020, European journal of medicinal chemistry,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
August 2007, FEMS immunology and medical microbiology,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
July 1984, Cancer,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
November 2020, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
January 1991, The Journal of protozoology,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
October 1992, Tissue antigens,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
September 2006, Expert review of anticancer therapy,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
February 1983, Clinical immunology and immunopathology,
Till Seiler, and Manuela Woelfle, and Sophia Yancopoulos, and Rosa Catera, and Wentian Li, and Katerina Hatzi, and Carol Moreno, and Marcela Torres, and Santanu Paul, and Hartmut Dohner, and Stephan Stilgenbauer, and Matthew S Kaufman, and Jonathan E Kolitz, and Steven L Allen, and Kanti R Rai, and Charles C Chu, and Nicholas Chiorazzi
May 2003, British journal of haematology,
Copied contents to your clipboard!